Hyderabad, which is emerging as the knowledge capital of the worlds life sciences , has grabbed another big-ticket Investment in the sector. US-based StemCures is slated to establish a manufacturing lab in Telangana that will focus on stem cell therapy with the vision to create the largest stem cell manufacturing plant in India. The facility will be set up with the investment potential of around USD 54 million and EMPLOYMENT potential for around 150 people in a couple of phases.
Currently, StemCures is culminating R&D of the stem cell line at Aspire Bionest in University of Hyderabad and is ready to embark on a phase 1 manufacturing lab.
Hyderabad already serves more than 1000 life sciences companies, including the top 10 pharma companies. Four of the top 10 global innovator companies now have a direct presence in Hyderabad through their dedicated centers. These centers drive core R&D, digital and engineering activities, thereby contributing to bringing lifesaving cost-effective therapies and devices to patients world-wide.